Upgrade your membership to see all of the expert analysis we have published on MRX now!

Medicis Pharmaceutical Corp's (MRX -$0.25 or -0.85% to $29.27) suffered a small loss on light volume today, still hovering in a tight range near its 52-week high with volume totals cooling. An upward trendline helps define the initial chart support level to watch above prior highs in the $28 area. Its fairly fresh breakout was shown under the 8/12/10 headline "Weak Finish Amounted To A Damaging Distribution Day" as it endured some selling pressure. It was noted in prior reports for its strong quarterly and annual earnings history. After its 8/06/10 breakout from a sound base, the high-ranked Medical - Ethical Drugs firm has risen with the help of a bullish market (M criteria) environment. Disciplined investors always limit losses by selling if any stock falls more than -7% from their purchase price.

Medicis Pharmaceutical Corp's (MRX -$0.36 or -1.35% to $26.40) was featured in the mid-day report today (read here) and noted for its strong quarterly and annual earnings history. Pulling back from its 52-week high after its 8/06/10 breakout from a sound base, the high-ranked Medical - Ethical Drugs firm had rebounded into positive territory after initially gapping down.  However, its early resilience faded today and it closed below its pivot point as a loss on higher volume amounted to another distribution day and some technical damage. In a bullish market environment, healthy stocks do not slump more than -7% below their pivot point. Disciplined investors always limit losses by selling if any stock falls more than -7% from their purchase price.